Phase II and pharmacodynamic studies of pyrazine diazohydroxide (NSC 361456) in patients with advanced renal and colorectal cancer

Nicholas J. Vogelzang, Sridhar Mani, Richard L. Schilsky, Rafat H. Ansari, David Taber, Steven N. Rhinehart, Juan C. Garcia, Steven C. Meyer, Rosemarie Mick, Bruce E. Brockstein, Walter M. Stadler, Mark J. Ratain, Everett E. Vokes

Research output: Contribution to journal › Article › peer-review